Search Results - "NIH"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Ethical issues in human population genetics

    Published 2021
    Table of Contents: “…Contents: The ethical issues in human genetics -- ELSI issues -- DNA in establishing identity -- DNA in unveiling the past -- DNA predicts the future -- Manipulation of DNA -- Ownership and control of DNA -- Deeper cultural changes -- Population genetics -- DNA in group history -- The Navajo people -- DNA in group stigma -- DNA in exploitation -- DNA and racism -- DNA and biological warfare -- The consent of a research population -- The NIH alternative for consent -- Control -- Confidentiality -- Return of information -- Benefit sharing.…”
    Get full text
    Series
    Electronic Video
  2. 2

    Ethical issues in human population genetics

    Published 2021
    Table of Contents: “…Contents: The ethical issues in human genetics -- ELSI issues -- DNA in establishing identity -- DNA in unveiling the past -- DNA predicts the future -- Manipulation of DNA -- Ownership and control of DNA -- Deeper cultural changes -- Population genetics -- DNA in group history -- The Navajo people -- DNA in group stigma -- DNA in exploitation -- DNA and racism -- DNA and biological warfare -- The consent of a research population -- The NIH alternative for consent -- Control -- Confidentiality -- Return of information -- Benefit sharing.…”
    Get full text
    Series
    Electronic Video
  3. 3

    RAS pathway and disease neurofibromatosis and beyond /

    Published 2014
    Table of Contents: “…Contents: Neurofibromatosis type 1 (NF1) -- NIH diagnostic criteria (Seven criteria for NF1) -- NF1 and the RAS pathway -- NF1 tumour biology -- Neurofibromin deficiency -- Two types of neurofibromas -- Plexiform neurofibroma in the neck and mouth -- Mechanisms of disease -- Mouse models of neurofibroma formation -- Imatinib mesylate treatment -- Clinical aspects of glomus tumours of fingertips -- Gastrointestinal stromal tumours -- MPNST in NF1 -- FDG-PET as a diagnostic tool -- Hotspots for recombination & NF1 microdeletion -- SUZ12-loss -- Cafe-au-lait (CAL) macules -- Skeletal defects in NF1 -- Learning disabilities in NF1 -- Simvastatin treatment for cognitive deficits -- Mosaicism for NF1 mutation -- Diagnostic problems -- SPRED1 mutations & molecular mechanism of Legius syndrome -- The RAS pathway proteins & genetic syndromes (RASopathies).…”
    Get full text
    Series
    Electronic Video
  4. 4

    RAS pathway and disease neurofibromatosis and beyond /

    Published 2014
    Table of Contents: “…Contents: Neurofibromatosis type 1 (NF1) -- NIH diagnostic criteria (Seven criteria for NF1) -- NF1 and the RAS pathway -- NF1 tumour biology -- Neurofibromin deficiency -- Two types of neurofibromas -- Plexiform neurofibroma in the neck and mouth -- Mechanisms of disease -- Mouse models of neurofibroma formation -- Imatinib mesylate treatment -- Clinical aspects of glomus tumours of fingertips -- Gastrointestinal stromal tumours -- MPNST in NF1 -- FDG-PET as a diagnostic tool -- Hotspots for recombination & NF1 microdeletion -- SUZ12-loss -- Cafe-au-lait (CAL) macules -- Skeletal defects in NF1 -- Learning disabilities in NF1 -- Simvastatin treatment for cognitive deficits -- Mosaicism for NF1 mutation -- Diagnostic problems -- SPRED1 mutations & molecular mechanism of Legius syndrome -- The RAS pathway proteins & genetic syndromes (RASopathies).…”
    Get full text
    Series
    Electronic Video
  5. 5

    RAS pathway and disease neurofibromatosis and beyond /

    Published 2014
    Table of Contents: “…Contents: Neurofibromatosis type 1 (NF1) -- NIH diagnostic criteria (Seven criteria for NF1) -- NF1 and the RAS pathway -- NF1 tumour biology -- Neurofibromin deficiency -- Two types of neurofibromas -- Plexiform neurofibroma in the neck and mouth -- Mechanisms of disease -- Mouse models of neurofibroma formation -- Imatinib mesylate treatment -- Clinical aspects of glomus tumours of fingertips -- Gastrointestinal stromal tumours -- MPNST in NF1 -- FDG-PET as a diagnostic tool -- Hotspots for recombination & NF1 microdeletion -- SUZ12-loss -- Cafe-au-lait (CAL) macules -- Skeletal defects in NF1 -- Learning disabilities in NF1 -- Simvastatin treatment for cognitive deficits -- Mosaicism for NF1 mutation -- Diagnostic problems -- SPRED1 mutations & molecular mechanism of Legius syndrome -- The RAS pathway proteins & genetic syndromes (RASopathies).…”
    Get full text
    Series
    Electronic Video